current user: public

If you have questions about the server, please let us know.

Query: 6e2g_A mol:protein length:727 Transient receptor potential cation channel subfamily V member 6, from PDB1018

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .
# Score Template Links and tools%idFirst MGWSLPKEKGLILCLWNKFCRWFHRRESWAQSRDEQNLLQQKRIWESPLLLAAKENNVQALIKLLKFEGCEVHQKGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLYSEDLEKDSGEKLEMARPFGAYLSFPTPSVSRSTSRSSTNWDRLRQGALRKDLQGIINRGLEDGEGWEYQILast
1 -222.0006e2g_A mol:protein length:727 Transient receptor potential cation channel subfamily V member 6  ali model  100  1MGWSLPKEKGLILCLWNKFCRWFHRRESWAQSRDEQNLLQQKRIWESPLLLAAKENNVQALIKLLKFEGCEVHQKGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLYSEDLEKDSGEKLEMARPFGAYLSFPTPSVSRSTSRSSTNWDRLRQGALRKDLQGIINRGLEDGEGWEYQI 727
2 -193.0006bo8_A mol:protein length:742 Transient receptor potential cation channel subfamily V member 6  ali model follow..  85  1.............MGLSLPKEKGWSKFCRWFQRRESNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGS---EDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGEAWSHP. 738
3 -188.0006b5v_A mol:protein length:730 Transient receptor potential cation channel subfamily V member 5  ali model follow..  73  2.............GACPPKAKGPWAQLQKLLISDRVNMLQQERIRDSPLLQAAKENDLRLLKILLLNQSCDFQQRGAVGETALHVAALYDNLEAATLLMEAAPELAKEPALCEPFVGQTALHIAVMNQNLNLVRALLARGASVSARATGAAFRRSPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDEHSDLQSLELVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHVQWTCGPLTSTLYDLTEIDSWGEELSFLELVVSSKKREARQILEQTPVKELVSFKWKKYGRPYFCVLASLYILYMICFTTCCIYRPLKLRDDNRTDPRDITILQQKLLQEAYVTHQDNIRLVGELVTVTGAVIILLLEIPDIFRVGASRYFGQTILGGPFHVIIITYASLVLLTMVMRLTNMNGEVVPLSFALVLGWCSVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFHITFQTEDPNNLGEFSDYPTALFSTFELFLTIIDGPANYSVDLPFMYCITYAAFAIIATLLMLNLFIAMMGDTHWRVAQERDELWRAQVVATTVMLERKMPRFLWPRSGICGYEYGLGDRWFLRVENHHDQNPLRVLRYVEAFKCSDKEDQEQLSEKRPSTVESGMLSRASVAFQTPSLSRTTSQSHRGWEILRRNTL-----GHLNLGLDLGEGDGEEV 727
4 -182.0005wo7_A mol:protein length:676 Transient receptor potential cation channel subfamily V member 6  ali model follow..  99  1MGWSLPKEKGLILCLWNKFCRWFHRRESWAQSRDEQNLLQQKRIWESPLLLAAKENNVQALYKLLKFEGCEVHQKGAMGETALHIAALYDNNEAAQVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLYSEDLEKDSGE............................................................ 667
5 -147.0006dvw_A mol:protein length:791 Transient receptor potential cation channel subfamily V member 3  ali model follow..  25  49.GFEPNPTVTKTSPPIFSKPMDSNIRQCLSGNCDDEEQRQKKKRLKKRIFAAVSEGCVEEL-RELLQDLQDLCRRSDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMENQTDITSQDSRGNNILHALVTVAENDFVKRMYDMILLRSGN---WELETMRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEIIVYNTNIDNRHEMLTLEPLHTLLHTKWKKFAKYMFFLSFCFYFFYNITLTLVSYYRPRED--------------EDLPHPLALTHKMSWLQLLGRMFVLIWATCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFVQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYILFLLGFGVALASLIEKKDKKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSTYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRMGELCKVADEDFRLCLRIN---EVKWTEWKTHVSFLNEDPGPIRRTADLNKIQDSSRSNSKTTLYAFDELDEFPETS.................................... 790
6 -142.0006bwj_A mol:protein length:776 Transient receptor potential cation channel subfamily V member 2  ali model follow..  23  1.......TSPSSPPAFRLETSDGGQDGAEVDKGAGASQPDLNRFDRDRLFNVVARGNPEDLAGLLKYLTDSEYTEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENPASLQAQDSLGNTVLHALVMIADDSLVVRMYDGLLQAGARCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIP-RFCFNFLCYLVYMLIFTAVAYHQPA---------------LEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYSEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVMGWTNLLYYTRGFQHTGIYSVMIEKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQNDEAPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRA-RPDGSPDERWCFRVGEMNWATWEQTLPRTLCEEPSGAAAPGVMKNPTPASQRGEDSASEEDHLPLQLLQSRDYKDDD................................ 767
7 -138.0006c8f_A mol:protein length:675 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  28  1..............................MAPSPDPPPVIKMFNRHMLFDIVSRGSTAELEGFLKRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTRENTKFVTKVKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEEVSVLELVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRPMDGTPP-----------------YPYRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRS-NLDGTPDRRWCFRVDEVNWSHWNQNLGIINEDPGRSNSLEV.................................................................... 672
8 -138.0005irx_A mol:protein length:636 Transient receptor potential cation channel subfamily V member 1  ali model follow..  26  1.....................................AMGSRLYDRRSIFDAVAQSNCQEL-ESLLPFLQRSKKRPETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEI-HPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCEKNSVLEVAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRP----------------VEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPS--LKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGK------YNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSFTPDGKDDYRWCFRVD---EVNWTTWNTNVGIINEDPG........................................................................ 636
9 -136.0006mho_B mol:protein length:826 Transient receptor potential cation channel subfamily V member 3  ali model follow..  24  50.GFEPNPTVAKTSPPVFSKPMDSNIRNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRTASDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMEHQTDITSRDSRGNNILHALVTVAEDDFVKRMYDMILLRSGN---WELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLA--------------LTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRMGELCKVAEDDFRLCLRIN---EVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKD------DDDKA..... 816
10 -135.0005an8_A mol:protein length:613 TRPV2  ali model follow..  26  2...............................................RLFNVVARGNPEDL-AGLLEYLRRTSKEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENAASLQAQDSLGNTVLHALVMIADNSPENSALVVRMYGARLCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIP-RFCFNFLCYLVYMLIFTAVAYHQPA---------------LEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQEDEAPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRA-RPDGSPDERWCFRVGE............................................................................................. 612
11 -134.0006bbj_A mol:protein length:868 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  25  19.SQGDDGSNHNDSFPLSSLANLFENEESSAPNEGVRSPQVPGMFNRHMLFDIVSRGSTAELEGFLKRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTRENTKFVTKVKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEESVLEILVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRPMDGTPP-----------------YPYRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRS-NLDGTPDRRWCFRVDEVNWSHWNQNLGIINEDPGRNDGYQSVVVPRVVELNKAPQHSDDVVVPLGNIPQVQTYSQRQENAQNWKKDE...................... 865
12 -131.0003j5p_B mol:protein length:598 Transient receptor potential cation channel subfamily V member 1  ali model follow..  27  2...........................................YDRRSIFDAVAQSNCQELESLL-KRLTDSEFKDETGKTCLLKAMLNGQNDTIALLLDVARKTDSASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILIPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCENSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPP----------------YKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPS--LKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGK------YNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAXXXXXXXXXXXX..................................................................................................... 598
13 -130.0005hi9_A mol:protein length:770 Transient Receptor Potential Cation Channel Subfamily V Member 2  ali model follow..  24  21.GNAEVNKGKQEPPPMESPFQREDRNSSPQIKVNAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLKYLTDSAYTEGSTGKTCLMKAVLNGVNACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADNSLVIHMYDGLLQMGARCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSTEWCYGPVRVSLYDLSSVDSWEKNSVLEIIAFHCKSPNRHRMVVLEPLNKLLQEKWDRLVSRFF-FNFACYLVYMFIFTVVAYHQP---------------SLDQPAIPSSKATFGESMLLLGHILILLGGIYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLRFMETEWYLPLLVLSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREARSEEPAPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNHVADNSWSIWKLQKAISVLEMENGYWWCRRKKHRE-RGDGTPDERWCFRVE---EVNWAAWEKTLPTLSEDPSGPGITGNKKNPTSKPGKNSASEEDHLPLQVLQSPTETSQV................................ 767
14 -75.8005vkq_A mol:protein length:1732 No mechanoreceptor potential C isoform L  ali model follow..  15  850.DRSGVRNKLTDATPLQLAAEGGHADVVKALVRAGASCTEENKAGFTAVHLAAQNGHGQ-VLDVLKSTNSLRINSKKLGLTPLHVAAYYGQADTVRELLTSVPATVKSFGDLGTESGMTPLHLAAFSGNENVVRLLLNSGVQVDAATENGYNPLHLQSQDRNGRTGLHIAAMHGHIQMVEILLGQGAEINATDRNGWTPLHCAAKAGHLEVVKLLCEAGASPKS----------ETNYGCAAIWFAASEGHNEVLRYLMNKEHDTYGLMEDKRFVYNLMVVSKNHNNKPIQEFVLVSPAPVDTAA--KLSNIYIVLSTKEKERAKDLVAAGKQCEAMATELLALAALQELWHGSLTWASWKILLLLVAFIVCPPVWIGFTFPMGHKFNKVPIIKFMSYLTSHIYLMIHLSIVGILRLSLVPYWYEVGLLIWLSGLLLFIKVLVLLLGMANQCFALAFLLACVQILDFLSFHHLFGPWAIIIGDLL-KDLARFLAVLAIFVFGFSMHIVALNQSFANFSMHPINSFELLFFAVFGQTTQVDKIKNVATPTQPYLFKIVFGIYMLVSVVVLIQLLIAMMSDTYQRIQAQSDIEWKFGLSKLIRNMHRT-PLNLVTTWFM-----------WIVEKVKARMKKKKRPSLVQMMGIRQASPRTKAGAKWLSKIKKDSVALSQVHLSPLGSQASFSQANQ-------------------NRIENVADWEAIA 1681
15 -74.3006d7l_A mol:protein length:853 Short transient receptor potential channel 3  ali model follow..  13  1.GAMGSMEGSPSLRRMTVMREKGRRQAVRGPAFMFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEEKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIG----------DALLLAISKGYVRIVEAILNHPGFAASKRLTLYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRINAYKGLASPAYLSLSSED-----PVLTALELSNELAKLANIEKEFKNDYRKLSMQCKDFVVGVLDLCRDSEEVEAILNGDLESAHRHKASLSRVKLAIKYEVKKFVAAIKCLVVLVVALGLPFLAIGYWIAPCSRLGKILRSPFMKFVAHAASFIKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQ------WNVLDFGMLSIFIAAFTARFLAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAFTTVEESFKTLFWSIFGLSEVTSVVLKYIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYGKTLPPYFIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQDSSLRYELLEDKSQATEELAILIHKL 841
16 -72.5003j9p_D mol:protein length:1528 Maltose-binding periplasmic protein, Transient receptor potential cation channel subfamily A member 1 chimera  ali model follow..  14  663.GAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGVNTTDGCHETMLHRASLFDHHE-LADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGA-LFLSDHNGWTALHHASMGGYTQTMKVILDTNLKC---------TDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLN----KQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIELTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGLIPMTILVVNIKPGMAFNSTGIINEDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQAIAVYFYWMNFLLYLQRFENCGIFIVMLEV-ILKTLLRSTVVFIFLLLAFGLSFYILLNLQDP-----FSSPLLSIIQTFSMMLGDINYRESNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLR--AVKAKTHH................ 1517
17 -71.2002rfa_A mol:protein length:232 Transient receptor potential cation channel subfamily V member 6  ali model follow..  97  2...........................................IWESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIAAA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 226
18 -69.5005yx9_A mol:protein length:931 Short transient receptor potential channel 6  ali model follow..  11  18.AAGAAARRNESQDYLLMDSELGEDGCPQAPLPCYSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILSHPAFAEGKRLATYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRI----------NAYKGLASPAYLSLSSEDPVMTALELSNELAVLANKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGD-NLSRLKLAIKYEVKKFVAH--FLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASFTKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFE------WNMLDFGMLAIFAASFIARFMAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVINYIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKR--RYVLQAQIDKESDEVNEGELKE----KQDI 891
19 -67.4005z96_A mol:protein length:755 Short transient receptor potential channel 4  ali model follow..  15  1............MAQFYYKRNVNAPYRDRIPLRI-VRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEININCIDPLGRTALLIAIENENLELIELLLSFNVYV------------GDALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIYKALASPSLIALSSED-----PFLTAFQLSWE--LQELSKVENEFKSEYEELSRQCKQLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKEFVAAVKMVTCFIIGLLFPVFSVCYLIAPKSPLGLFIRKPFIKLLLASQHIDRSDLNRQGPPPTIVEWMILPWVLGFIWGEIKQMWDGGLQDYIHDW-----WNLMDFVMNSLYLATISLKIVAFVKYEALFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYEETKNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSYFEELPT------------------WYLVKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAAMIREAKTEEGLTEENVKELKQSSFRFEVLGLLR............. 755
20 -65.7006cv9_A mol:protein length:842 Short transient receptor potential channel 6  ali model follow..  12  1....................................AMGSMLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILNHPAFAEGKRLATYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCTECSQKQKHDSFSHSRSRINAYKG----------LASPAYLSLSSEDPVMTALELSNELAVLANKNDYRKLSMQCKDFVVGLLDLCRNTEEVEAILNGDAETRDFGRPNLSRLKLAIKYEVKKFVAH--FLVVLAVAIGLPFLALIYWCAPCSKMGKILRGPFMKFVAHAASFTRQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFE------WNMLDFGMLAIFAASFIARFMAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEFTTVEESFKTLFWAIFGLSEVKSVVINYIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYGRTLPVLLKFKKWMCELIQGQKQGFQEDAEMNKRNEEKKFGISGSHEDLSKFSLDKNQLAHNKQSSTRSSEDYHLNSFSNPPRQYQKIMKRLIKRYVLQAQIDKESDEVNEGELKE----KQDI 802
21 -64.9002nyj_A mol:protein length:273 Transient receptor potential cation channel subfamily V member 1  ali model follow..  30  1................................SVSAGEKPPRLYDRRSIFDAVAQSNCQ-ELESLLPFLQRSKKRPETGKTCLLKAMLNGQNDTIALLLDVARKTDSASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILIPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEP............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 260
22 -64.4004dx1_A mol:protein length:259 Transient receptor potential cation channel subfamily V member 4  ali model follow..  32  2...........................................FNRPILFDIVSRGSTADLDGLLKRLTDEEFREPSTGKTCLPKALLNGRNDTIPVLLDIAERFINSPFRDIYYRGQTALHIAIERRCKHYVELLVAQGADVHAQARGRFFQPKEGGYFYFGELPLSLAACTNQPHIVNYLTENKADMRRQDSRGNTVLHALVAIADNKMYDLLLLKCARLFPDSN---LEAVLNNDGLSPLMMAAKTGKIGIFQHIIRREVTDEAA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 252
23 -64.1002etc_A mol:protein length:274 Transient receptor potential cation channel subfamily V member 2  ali model follow..  33  3................................TSAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLKYLTDSAYTEGSTGKTCLMKAVLNLQDACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADSALVIHMYDGLLQMGARCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREF--SGPYQPLAAA.................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 268
24 -62.1004b93_B mol:protein length:269 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  18  2..QEETKKDYREVEKLLRAVADGDLEMVRYLLEWTEEVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANA-----GARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLS-------------GNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQV----------LNKRQRTAVDCAEQNSKIQVVPSCVASLDDVAETDRKEYVTVK.................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 260
25 -61.9003ljn_A mol:protein length:364 hypothetical protein  ali model follow..  16  10.KLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVD-TAKYLASVGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGAKEVNEIGSHVKHCKGQTALHWCVGLGYLEMIKILVQLGASPTAKDKA-------------DETPLMRAMEFRNREALDLMMDSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNM----------EDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSSAVSK.......................................................................................................................................................................................................................................................................................................................................................................................... 364
26 -61.3003jxi_A mol:protein length:260 Vanilloid receptor-related osmotically activated channel protein  ali model follow..  31  2.........................................KVFNRPILFDIVSRGSPDGLLSFLLTHKKRLFREPSTGKTCLPKALLNGRNDTIPILLDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGADLRRQDSRGNTVLHALVAIADNKMYDLLLIKCAKLFPDTN---LEALLNNDGLSPLMMAAKTGKIGIFQHIIRREI................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 249
27 -60.6004nik_A mol:protein length:230 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  20  1.GSHMMEGCVSNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTE-IVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQV-----NAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHY-------------EATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIY----------IENKEEKTPLQVAKG-GLGLILKRMVEG.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 230
28 -60.4001n11_A mol:protein length:437 Ankyrin  ali model follow..  18  4.GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTE-VAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP-----NLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANA----------ESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLT---PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYS------PLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE.................................................................................................................................................................................................................................................................................................................................. 402
29 -60.4002f37_A mol:protein length:251 Transient receptor potential cation channel subfamily V member 2  ali model follow..  24  4........NRFDRDRLFNAVSRGVPEDLAGLPEYLSKTSKY---LTDSEYTEGSTGKTCLMKAVL-------NLKDGVNACILPLLQIDRDSGNPQPLVN-------AQCTDDYYRGHSALHIAIEKRSLQCVKLLVENGANVHARACGRFFQKGQGTCFYFGELPLSLAACTKQWDVVSYLLENPASLQATDSQGNTVLHALVMISDNSAENIALVTSMYDGLLQPTVQLEDIRNLQDLTPLKLAAKEGKIEIFRHILQREFS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 251
30 -60.1002f8x_K mol:protein length:256 Neurogenic locus notch homolog protein 1  ali model follow..  17  1.GMDVNVRGPDGFTPLMIASCSGGPAVISDFIYQGASLNQTDRTGETALHLAARYSRSD-AAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRD----------ITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 251
31 -60.1004n5q_A mol:protein length:257 Transient receptor potential cation channel subfamily V member 3  ali model follow..  34  3............................................LKKRIFAAVSEGCVEEL-RELLQDLQDLCRRRRTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMENETDITSQDSRGNNILHALVTVAENDFVKRMYDMILLRSGNWE---LETMRNNDGLTPLQLAAKMGKAEILKYILSREIK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 250
32 -59.4006ar6_B mol:protein length:328 DLD-4 darpin  ali model follow..  19  26.GADVNADDRIGMTPLHLAAIGGHLEIVEVLLKNGADVNADDVHGRTPLHLAAGRGHLE-IVEVL--HGADVNAPDRWGRTPLHLAAHHGHLEIVEVLLKYGADV-----NAQDKFGKTAFDISIDSGNEDLAEILQSSSEFGGGGSGGG--GSGGGGSASDLGKKLLEAARAGQDDEVRILMANGADVNATDHLGVTPLHLAAVLGHLEIVEVLLKHGADVNA----------YDILGRTPLHLAAWRGHLEIVEVLLKYGADVNADDTSGTT---PLHLAAGEGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEIL................................................................................................................................................................................................................................................................................................................................................................................................................ 328
33 -59.1006g1k_A mol:protein length:921 Transient receptor potential cation channel subfamily c member 4a  ali model follow..  13  1..............GSQLYFRRTDNSSYRDRIPRIVRAESELSTQEKSYLSAVEKGDYASVKLALEEAEININCIDPLGRTALLIAIENENLEIIELLLSFNVYV------------GDALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSDFTPDITPIILAAHTNNYEIIKMLVQKGVSVPQPHEVRCNCVECVSSSDVDSLRHSRSRLNIY-----KALASPSLIALSSEDPFLTAFQLSWE--LQELSKVENEFKAEYEELSHQCKHLDQTRSSRELELILNFRDDMNLLQDEANNELARLKLAIKYRQKEFVAIKFICHTASYLTFLFLLLLASQHI-----------------------VSNNPDRQGPKPTTVEWMILPWVLGFIWTEIKQMWDGGFQDYIHDW-----WNLMDFVMNSLYLATISLKIVAYVKYEAVFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYENSENNAFSTLFETLQSLFWSIFGLISLYVTNVKADEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQHIADHADIEWKFARTKLWMSYFEELPP-------------------IIPSPKSICYLITWIKVHVFKRRSKRTETFGTLGRRAAENVRLNHQYQEVLRNLVKRYVAAMIRDAKTEEGLTEENFKELKQDISSFRYE......... 748
34 -58.0001oy3_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  20  2....FGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGLDLQNDLGQTALHLAAILGEAS-TVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPED----------GGDKLSPCSSSGSDSDSDNRDEGDEYD................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 281
35 -57.9001k3z_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  20  2....FGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGLDLQNDLGQTALHLAAILGEAS-TVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPED----------GGDKLSPCEEEGEDEDSDNRDEGDEYD................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 281
36 -57.6002dvw_A mol:protein length:231 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  21  2........................................EGCVSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPV-----NDKDDAGWSPLHIAASAGRDEIVKALLVKGAHVNAVNQN-------------GCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNI----------QDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQ------AKGGLGLILKRLAEGEEAS......................................................................................................................................................................................................................................................................................................................................................................................................................................... 230
37 -57.5006by9_A mol:protein length:328 Histone-lysine N-methyltransferase EHMT1  ali model follow..  15  1...........GSAAGPPLSEDDKLQGAASHVPEGFDPTGPAGLGRPTPGLSQGPGKET-LESALIALDSEKPKKLRFHPKQLYFSARQGELQKVLLMLVDGIDPNF---KMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSED-------------QRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNG---------QMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENI---CLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGET------PLQCASLNSQVWSALQMSKALQ.................................................................................................................................................................................................................................................................................................................................................................... 325
38 -57.4002qc9_A mol:protein length:210 Notch 1 protein  ali model follow..  20  2.........................SVISDFIYQGASLNQTDRTGETALHLAARYSRSD-AAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILLRNRA----TDLDARMHDGTTPLILAARLALEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNKEETPLFLAAREGSYETAKVLLDHFANRD----------ITDHMDRLPRDIAQERMHHDIVRLLDEY.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 210
39 -57.3001ot8_A mol:protein length:239 Neurogenic locus Notch protein  ali model follow..  18  2...........GLTPLMIAAVRGTAQVISDLLAQGAELNATDKTGETSLHLAARFARAD-AAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRA----TNLNARMHDGTTPLILAARLAIEGMVEDLITADADINAADNS-------------GKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANRE----------ITDHMDRLPRDVASERLHHDIVRLLDEH.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 239
40 -57.3005le6_A mol:protein length:324 DD_D12_09_D12  ali model follow..  20  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPRDLARLLDALKYLLLEAAREGHRDRVEKLIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 318
41 -57.3001ikn_D mol:protein length:236 PROTEIN (I-KAPPA-B-ALPHA)  ali model follow..  19  2.....QQLTEDGDSFLHLAIIHEEMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPE-IAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSLKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEP------------CNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQ----------MLPESEDEESYDTESEFTEFTE....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 234
42 -56.9002eta_A mol:protein length:256 Transient receptor potential cation channel subfamily V member 2  ali model follow..  26  2...........DRDRLFSVVSRGVPEELTGLLEYLRWNSKY---LTDSAYTEGSTGKTCLMKAVL-------NLQDGVNACIMPLLQIDKDSGNPKPLVN-------AQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADNSLVIHMYDGLLQMGARCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAAA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 250
43 -56.9004o60_A mol:protein length:234 ANK-N5C-317  ali model follow..  29  2........SMDIGKKLLEAARAGHDDSVEVLLKKGADINAKDNVGVTPLHLAAVNGHLE-LVKLLLEKGADINATDLFGLTPLHFAATNGHLELVKLLLEKGADI-----NAVDDVGVTPLHFAARNGHLELVKLLLEKGADINAMDMV-------------GPTPLHFAAKNGHLELVKLLLEKDADINAEDHFGSTPLHSAAENGHLELVKLLLEKGADINA----------RDKFGKTPFDLAIDNGNEDIAEVLQKAARS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 228
44 -56.8004qfv_A mol:protein length:234 ANK-N5C-281  ali model follow..  29  2........SMDIGKKLLEAARAGHDDSVEVLLKKGADINAKDNSGRTPLHVAALNGHLE-LVKLLLEKGADINARDMFGLTPLHTAASNGHLELVKLLLEKGADI-----NARDEDGSTPLHLAASNGHLELVKLLLEKGADINAEDHS-------------GTTPLHFAAKNGHLELVKLLLEKGADINASDFSGPTPLHSAAENGHLELVKLLLEKGADINA----------RDKFGKTPFDLAIDNGNEDIAEVLQKAARS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 228
45 -56.8005le9_A mol:protein length:324 DD_Off7_09_3G124  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLE-IVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVSAQDKFGKTPRDWKLLLDALKYLLLEAAREGHRDRVEKLIKAGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVN----------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHT---PLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 318
46 -56.7004rlv_A mol:protein length:910 Ankyrin-1, Ankyrin-2  ali model follow..  14  293.GAAVDFTARNGITPLHVASKRGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQ-VVELLLERGAPLLARTKNGLSPLHMAAQGDHVECVKHLLQHKAPV-----DDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALN-------------GFTPLHIACKKNRIKVMELLVKYGASIQAITESGLTPIHVAAFMGHLNIVLLLLQNGASPDV----------TNIRGETALHMAARAGQVEVVRCLLRNGALVDARAREEQT---PLHIASRLGKTEIVQLLLQHMAHPDAATTNGYTPLHISAREGQVDVASVLLEAGAAHSLATKKGFT------PLHVAAKYGSLDVAKLLLQRRAAADSAGKNGLTPLHVAAHYDNQKVALLLLEKGASPHATAKNGY------------------------TPLHIAAKKNQMQIASTLLNYG-VTPLHLASQEGHTDMVTLLLDKIHMSTKSGLTSLHLAAQEDKVNVADILTKHGADQDAHTKLGYTPLIVACHYGNVKMVNFLLKQGANVNAKTKNGYTPLHQAAQQGHTHIINVLLQHGAKPNATTANGNTALAIAKVDTLKVVT......................................................................................................................... 854
47 -56.6003utm_A mol:protein length:351 Tankyrase-1  ali model follow..  16  2......................EFGKSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADV-----HAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLW-------------QFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAARELEIINFKQPQSHETALHCAVASLHKQVAELLLRKGANVNEKNKDFMT---PLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAA.............................................................................................................................................................................................................................................................................................................................................................................................. 317
48 -56.6005w7i_A mol:protein length:239 Palmitoyltransferase ZDHHC17  ali model follow..  23  1.GPHMKTHDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRID-LVKYYISKGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADP-----SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQN-------------GMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKHKNTALHWAVLAGNTTVISLLLEAGANVDA----------QNIKGESALDLAKQRKNVWMINHLQEARQA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 238
49 -56.6005y4e_A mol:protein length:277 Ankyrin-2,Ankyrin-2  ali model follow..  22  5.YLRPEDLKELGDDSLPSSQFLDGMNYLRYSLEGGRSLGSGSRNGITPLHVASKRGNTN-MVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQVVELLLERGAPL-----LARTKNGLSPLHMAAQGDHVECVKHLLQHKAPVDDVTLD-------------YLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQA----------ITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGET---ALHMAARAGQVEVVRCLKVVTEEVTT........................................................................................................................................................................................................................................................................................................................................................................................................................................ 277
50 -56.6001yyh_A mol:protein length:253 Notch 1, ankyrin domain  ali model follow..  17  1..MDVNVRGPDGFTPLMIASCSGGPAVISDFIYQGASLNQTDRTGETALHLAARYSRSD-AAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRD----------ITDHMDRLPRDIAQERMHHDIVRLLDLE.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 245
51 -56.6004cym_D mol:protein length:203 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  19  2..........................PLGSMDPSVVTPFSRDDRGHTPLHVAAVCGQAS-LIDLLVSKGAMVNATDYHGATPLHLACQKGYQSVTLLLLHYKASA-----EVQDNNGNTPLHLACTYGHEDCVKALVYYDVE----------SCRLDIGNEKGDTPLHIAARWGYQGVIETLLQNGASTEIQNRLKETPLKCALNSKILSVME-------------AYHLSFERRQKSSEAPVQSPQRSVD............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 197
52 -56.4005leb_A mol:protein length:473 DDD_D12_06_D12_06_D12  ali model follow..  17  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNA----------TDVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDALLEAARQGQRDRVEKLMANGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHT------PLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADV................................................................................................................................................................................................................................................................................................................................. 437
53 -56.3001ycs_B mol:protein length:239 53BP2  ali model follow..  15  2........EITGQVSLPPGKRTNLRKTGSERIAHGMRVKF-NPLPLALLLDSSLEGEFD-LVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNV-----NAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSD----------MQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDEL---PMKEGDCMTIIHREDEDERLNDKEGYVPRNLLGLYPRIKPRQRSLA................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 239
54 -56.2005et0_A mol:protein length:354 Espin  ali model follow..  15  28.LLGPSLRDSLDALPVHHAARSGKLHCLRYLVEEVAPAVSRARNGATPAHDAAATGYLSCLQWLLTQGGCRVQEKDNSGATVLHLAARFGHPDVVKWLLYQGG----ANSAITTDTGALPIHYAAAKGDLPSLKLLVGHYPE------------GVNAQTNNGATPLYLACQEGHLEVTKYLVQESADPHLRAQDGMTPLHAAAQMGHNPVLVWLVSFA---------DVSFSEQDHDGATAMHFAASRGHTKVLSWLLLHGAEISQDLWGGT----PLHDAAENGELECCQILAVNGAGLDVRDHDGYTAADLAEFNGHTHCSRYLRTVQTL------LEHRVLSRDQSMDLEAKQLDS............................................................................................................................................................................................................................................................................................................................................................................... 354
55 -56.2004rly_A mol:protein length:329 Nav1.2 - AnkB chimera  ali model follow..  20  23.SLVPRGSKSDSNASFLRAARAGNLDKVVEYLKGGIDINTCNQNGLNALHLAAKEGHVG-LVQELLGRGSSVDSATKKGNTALHIASLAGQAEVVKVLVKEGANI-----NAQSQNGFTPLYMAAQENHIDVVKYLLENGANQSTATED-------------GFTPLAVALQQGHNQAVAILLENDTKGK----VRLPALHIAARKDDTKSAALLLQNDHNADVQSKMM--VNRTTESGFTPLHIAAHYGNVNVATLLLNRGAAVDFTARNGIT---PLHVASKRGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQVVELLKVVTEEVTT....................................................................................................................................................................................................................................................................................................................................................................................................... 329
56 -56.1005le3_A mol:protein length:317 DD_D12_09_D12  ali model follow..  20  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPGDLAGDNGNEWIALLAAAREGHREAVERAIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 311
57 -56.1005lem_A mol:protein length:326 DD_Off7_11_3G124  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLE-IVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNA----------ADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHT---PLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 320
58 -55.9005le7_A mol:protein length:328 DD_D12_13_D12  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPEDEEAKKEDLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 322
59 -55.8005jhq_A mol:protein length:482 Tankyrase-1  ali model follow..  17  4.MASTGVPAVSALRELLEACRNGDVSRVKRLVD-AANVNAKDMAGRSPLHFAAGFGRKD-VVEHLLQMGANVHARDDGGLIPLHNACSFGHAEVVSLLLCQGADP-----NARDNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIRNTDGKSALDCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNA----------MDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPQVTELLLRKGANVNEKNKDFMT------PLHVAAERAHNDVMEVLHKHGAKMNALDTLGQTALHRAALAGHLQTCRLLLSYGSDP................................................................................................................................................................................................................................................................................................................................. 450
60 -55.7005le4_A mol:protein length:326 DD_D12_11_D12  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGALVKAKDKFGKTPKDLARDNGNLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 320
61 -55.7001k1a_A mol:protein length:241 B-cell lymphoma 3-encoded protein  ali model follow..  21  2....ATRADEDGDTPLHIAVVQGNLPAVHRLVNGGRELDIYNNLRQTPLHLAVITTLPS-VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAP-GTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKS------------GRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSS----------LKNCHNDTPLMVARSRRVIDILRGKATRPAS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 241
62 -55.6005lw1_A mol:protein length:326 DD_232_11_D12  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNASDQLGITPLHLVAITGHLE-IVEVLLKNGADVNAHDFVGTTPLHLAAFLGHLEIVEVLLKYGADV-----NAVDRDGLTPLHLAAIHGHLEIVEVLLKHGALVKAKDKFGKTPKDLARDAELLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 320
63 -55.3006fes_A mol:protein length:367 D12_BRIC2, a synthetic protein,D12_BRIC2, a synthetic protein  ali model follow..  12  29.GADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLE-IVEVLLKNGAGVNATDVIGTAPLHLAAMWGHEEIVEVLLKNGADA-----RAQDKFGKTPEDLARDNGYESVARLARKEIIRAVVDELKELVHTMKEITETMGFSPVALVL-EAIMMLVKLMLNSEIKI--------TSDLIDAVKKMLDMVTRLLDLMVDPNL-----------NEEQYIKMVVDALKILIEAVNVLIK-MVEKNPEDMEFWNLIYMKEVTETMGFSSVAKVLHTIMNLVDKMLNSEIKITSDLIKKKLDMVTRELDKMVS........................................................................................................................................................................................................................................................................................................................................................................................................... 367
64 -55.3003eu9_A mol:protein length:240 Huntingtin-interacting protein 14  ali model follow..  22  1...HMTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRID-LVKYYISKGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADP-----SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQN-------------GMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKHKNTALHWAVLAGNTTVISLLLEAGANVDA----------QNIKGESALDLAKQRKNVWMINHLQEARQAKGYD........................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 239
65 -55.2005aqa_A mol:protein length:418 OFF7_DB04V3  ali model follow..  15  1....MRGSGSDLGRKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLE-IVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYKEIVEVLLKAGADVDAQDKF-------------GKRPLWLAADQGHAEIAAKLVAARLKARVGYIELDLNSGKISEERFPMMSTFKVLLAGAILSRIELASAAITMSDNTAANLLLTTIGGPKGLTAFLHNMGDHVTRLDR----WEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQQLMDWGPLLRSVLPAGWFIA--DKSGAGERGSRGIVAALGPDGKPSRIVVIYTTGSQATMDILNEAIAMLGRAMI................................................................................................................................................................................................................................................................................................................................................. 409
66 -55.1006f5e_A mol:protein length:325 DD_D12_10_47  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPYDLATKRAALRRKLLEAARAGHRDEVEDLIKNGADVNAIDAMGLTPLHLAAMRGHLEIVEVLLKYGADVNA----------EDYYGTTPLRLAAYIGHLEIVEVLLKYGADVNAYDISGTT---PLHLAAVLGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQ............................................................................................................................................................................................................................................................................................................................................................................................................... 316
67 -54.9005le8_A mol:protein length:330 DD_D12_15_D12  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILLANGADVNTADETGFTPLHLAAWEGHLG-IVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVRAQDKFGKTPKKAERKLKDLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTA---PLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 324
68 -54.8005lea_A mol:protein length:327 DD_Off7_12_3G124  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLE-IVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGAAVGAQDKFGKTPKDLARDNKDLRRKLLEAARAGHREEVEKLIKLGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNA----------ADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHT---PLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 321
69 -54.7005lel_A mol:protein length:325 DD_Off7_10_3G124  ali model follow..  19  1....MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLE-IVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKFGKTPYDLATKRAALRRKLLEAARAGHRDEVEDLIKNGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNA----------ADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHT---PLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................ 319
70 -54.7005ma5_A mol:protein length:302 K11  ali model follow..  20  1......GPGSDLGKKLLEAARAGQDDEVRILMANGADVNAADDVGVTPLHLAAQRGHLE-IVEVLLKYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADV-----NARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKF-------------GKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHKAA-WGHLEKVEDLLKNGADVNA----------ADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDQAGFT---PLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPFDLAIDNGNEDIAEILQ............................................................................................................................................................................................................................................................................................................................................................................................................... 299
71 -54.6005aar_A mol:protein length:185 POTASSIUM CHANNEL AKT1  ali model follow..  22  3..............................................LNLCFAAIREDDL-LLHQLLKRGLDPNESDNNGRTPLHIAASKGTLNCVLLLLEYHADP-----NCRDAEGSVPLWEAMVEGHEKVVKVLLEHGSTIDAGDVGHFAC---------------TAAEQGNLKLLKEIVLHGGDVTRPRATGTSALHTAVCEENIEMVKYLLEQGADVNK----------QDMHGWTPRDLAEQQGHEDIKALFRE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 185
72 -54.5005ma9_A mol:protein length:305 R11  ali model follow..  20  1...RXXGPGSDLGKKLLEAARAGQDDEVRILMANGADVNAADDVGVTPLHLAAQRGHLE-IVEVLLKYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADV-----NARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKF-------------GKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHRAA-WGHLELVEKLLKNGADVNA----------ADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDQAGFT---PLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................... 302
73 -54.5005g4x_A mol:protein length:348 SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3  ali model follow..  11  18.LQQTKCLRLDPTAPVWAAKQRVLCALAGKFLDEERLLQDYPPNLDTPLPYLEFRYKRRVYAQNLIDDKQFAKLHTKANLKKFMDYVQLHSTDKVARLLDKGLDPNFHDPDS----GECPLSLAAQDNATDLLKVLRNGGAHLDFRTRD-------------GLTAVHCATRQRNAGALTTLLDLGASPDYKDSRGLTPLYHSALGGGALCCELLLHDHAQLG----------TTDENGWQEIHQACRFGHVQHLEHLLFYGANMGAQNASGNT---ALHICALYNQESCARVLLFRGANKDVRNYNSQTAFQVAIIAGNFELAEVIKTHKDSDVV....................................................................................................................................................................................................................................................................................................................................................................................................... 344
74 -54.4004uuc_A mol:protein length:226 ANKYRIN REPEAT AND SOCS BOX PROTEIN 11  ali model follow..  18  1........SMADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGHVA-CAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEV------HLASPIHEAVKRGHRECMEILLANNVNIDHEVPQ-------------LGTPLYVACTYQRVDCVKKLLELGASVD-HGQWLDTPLHAAARQSNVEVIHLLTDYGANLKR----------RNAQGKSALDLAAPKSSVEQALLLREGPPAL.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 226
75 -54.2005le2_A mol:protein length:491 DDD_D12_15_D12_15_D12  ali model follow..  16  31.GADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLE-IVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADV-----RAQDKFGKTPKDLARDNGNEWIRELLEKAERKLKDLDRKLLEAADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNA----------TDVIGTAPLHLAAMWGHLEIVEVLLKNGADVRAQDKFGKTPKDKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHT------PLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADV................................................................................................................................................................................................................................................................................................................................. 455

FFAS is supported by the NIH grant R01-GM087218-01
1 3 7 8 0 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Sasin JM, Godzik A, Bujnicki JM. SURF'S UP! - protein classification by surface comparisons. J Biosci. 2007 Jan;32(1):97-100.